Gitte B. Kerndrup

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.

Journal: Bone marrow transplantation
Published: June 03, 2021

Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.

Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.

Journal: Cytometry. Part B, Clinical cytometry
Published: June 19, 2020

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.

Journal: Blood advances
Published: October 28, 2019

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma.

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma.

Journal: Clinical hematology international
Published: October 04, 2019

Autoimmune Hepatitis and Seronegative Hepatitis Associated With Myelodysplastic Syndrome in Children.

Autoimmune Hepatitis and Seronegative Hepatitis Associated With Myelodysplastic Syndrome in Children.

Journal: Journal of pediatric hematology/oncology
Published: July 29, 2016

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

Journal: British journal of haematology
Published: March 18, 2016

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome.

Journal: Haematologica
Published: October 15, 2015

Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia-association with young age and myeloid sarcomas?

Rare MLL-ELL fusion transcripts in childhood acute myeloid leukemia-association with young age and myeloid sarcomas?

Journal: Experimental hematology & oncology
Published: January 01, 2015

t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.

t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.

Journal: Haematologica
Published: January 21, 2014

Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.

Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.

Journal: Haematologica
Published: October 29, 2013

Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.

Fusion of ZMYND8 and RELA genes in acute erythroid leukemia.

Journal: PloS one
Published: December 28, 2012

Efficacy of anti-IL-1 treatment in Majeed syndrome.

Efficacy of anti-IL-1 treatment in Majeed syndrome.

Journal: Annals of the rheumatic diseases
Published: October 23, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026